Publication | Closed Access

Identification of novel drug resistance mechanisms by genomic and transcriptomic profiling of glioblastoma cells with mutation-activated EGFR

Neuro-oncologyRadiation OncologyTranscriptomic ProfilingCancer GenomicsHigh-grade GliomasCell BiologySystems BiologyMedicineGliomaTumor BiologyCancer GrowthGlioblastoma CellsMutation-activated Egfr